What is the reported subcutaneous bioavailability of mecasermin in healthy subjects?

The reported bioavailability of mecasermin after subcutaneous administration in healthy subjects is approximately 100%; absolute subcutaneous bioavailability in subjects with severe Primary IGFD has not been determined.